ascopubs.org

Navigating third-line therapies: A comprehensive review of regorafenib versus fruquintinib with placebo comparator for metastatic colorectal cancer—A systematic review and ...

Safety of fruquintinib in young and late-elderly Chinese patients with colorectal cancer in real-world clinical practice: Age subgroup analysis of a fruquintinib phase IV study. This is an ASCO ...
EurekAlert!

Meta-analysis finds that beta-blockers improve outcomes after a heart attack in patients with mildly reduced heart function

The effects of beta-blocker therapy in post-myocardial infarction (MI) patients with mildly reduced left ventricular ejection fraction (LVEF 40−49%) are largely unknown.  A prespecified, individual ...
ascopubs.org

Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade

We systematically searched PubMed, Embase, and Scopus for phase III randomized controlled trials (RCTs) leading to BC drug approval between 2013 and 2023 that had available hazard ratios (HRs) for ...